Hypoxia regulates multiple oncogenic regulatory mechanisms mainly via the major oxygen-sensitive molecular mediators known as hypoxia-inducible factors (HIFs), activating a number of HIF- and non-HIF-associated signaling pathways and cellular processes namely MAPK/ERK, NF-κB, STAT3, PI3K/Akt, Wnt, p53 and glycolysis.
Hypoxia-Regulated
ZM 241385, Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptorCas#:139180-30-6
Starting at $107.90
SCH 58261, Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptorCas#:160098-96-4
Starting at $94.90
MRS 1754, Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptorCas#:264622-58-4
Starting at $151.90
FK866 (APO866, Daporinad), Nicotinamide phosphoribosyltransferase inhibitorCas#:658084-64-1
Starting at $72.90
- IB-MECA, Agonist of A 1 receptor;Agonist of A 2A receptor;Agonist of A 2B receptor;Agonist of A 3 receptor
Cas#:152918-18-8
Starting at $129.90
-
-
-
-
-
-
